The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Drug Screening Market Over The 2026–2030 Period?
The drug screening market has experienced rapid expansion in recent years. Its size is projected to increase from $9.72 billion in 2025 to $11.18 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.0%. This growth in the past can be ascribed to several factors, including the rising number of workplace drug testing programs, the expansion of clinical trial activities, increased screening demands from law enforcement, the proliferation of diagnostic laboratories, and the broader access to rapid test kits.
The drug screening market is projected for substantial expansion in the coming years, with its size expected to grow to $19.2 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. This growth during the forecast period is primarily driven by factors such as the increasing adoption of AI-enabled screening analytics, a rising demand for portable drug testing devices, the expansion of regulatory drug compliance testing, the growing use of real-time reporting systems, and innovation in multi-panel drug screening. Major developments expected in the forecast period include the increasing adoption of rapid drug testing kits, the rising use of automated laboratory screening systems, the growing integration of digital reporting solutions, the expansion of point-of-care drug testing, and an enhanced focus on high-accuracy detection.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6369&type=smp
What Underlying Factors Are Accelerating The Growth Of The Drug Screening Market?
The rising consumption of drugs and alcohol is anticipated to fuel the expansion of the drug screening market in the foreseeable future. Drug addiction is a condition that impacts an individual’s brain and behavior, leading to an inability to manage the intake of legal or illegal drugs or medications. Substances like alcohol, marijuana, and nicotine are also classified as drugs. As drug and alcohol addiction rises, the likelihood of related diseases increases, thereby stimulating the demand for drug screening. For example, in June 2025, the United Nations Office on Drugs and Crime, an Austria-based UN organization, reported that 316 million people used a drug (excluding alcohol and tobacco) in 2023, which accounted for six percent of the population aged between 15 and 64. With 244 million users, cannabis remained the most commonly used drug, succeeded by opioids with 61 million users, amphetamines with 30.7 million users, cocaine with 25 million users, and “ecstasy” with 21 million users. Therefore, the increasing consumption of drugs and alcohol is a primary driver for the growth of the drug screening market throughout the forecast period.
How Is The Drug Screening Market Segmented Across Key Categories?
The drug screening market covered in this report is segmented –
1) By Products: Rapid Testing Devices, Consumables, Other Products
2) By Sample Type: Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types
3) By End User: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges
Subsegments:
1) By Rapid Testing Devices: Urine Drug Test Kits, Saliva Drug Test Kits, Blood Drug Test Devices, Instant Test Strips
2) By Consumables: Reagents and Assays, Sample Collection Devices, Calibration Standards
3) By Other Products: Laboratory Equipment, Software Solutions, Storage and Transport Solutions
Which Upcoming Trends Are Expected To Influence The Drug Screening Market?
Leading firms within the drug screening market are increasingly prioritizing strategic alliances and joint ventures to enhance their financial stability, broaden their product offerings, and extend their global reach. Such collaborations involve an agreement where multiple entities work towards common goals while retaining their individual organizational autonomy. For example, in February 2025, Neopharma Technologies, a Canadian drug testing firm, and Impairment Science, a U.S.-based cognitive assessment company, declared a strategic partnership intended to transform drug and impairment screening. This joint effort integrates Neopharma’s NEOVAULT platform, which digitally processes and delivers rapid drug test outcomes, with Impairment Science’s DRUID cognitive impairment assessment, an AI-powered instrument designed for evaluating functional impairment. Through the fusion of these two technologies, the alliance seeks to boost the precision and applicability of drug screening, offering immediate data on both drug presence and functional impairment. This collaboration has the potential to enhance workplace safety, compliance with regulations, and decision-making in critical safety contexts by utilizing AI and digital reporting advancements.
Who Are The Dominant Players Shaping The Drug Screening Market Landscape?
Major companies operating in the drug screening market are Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE
Read the full drug screening market report here:
https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report
Which Region Is Projected To Dominate The Drug Screening Market During The Forecast Period?
North America was the largest region in the drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Drug Screening Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=6369&type=smp
Browse Through More Reports Similar to the Global Drug Screening Market 2026, By The Business Research Company
Pharmaceuticals Market 2026
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market
Drug Discovery Services Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report
Pharmaceutical Label Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-label-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model